Dr. Satyarani Tallapureddy, MD

Dr. Tallapureddy practices at Mouli Associates in South Windsor, Connecticut.

Dr. Tallapureddy's NPI, 1467470740, was assigned on July 17, 2006. Dr. Tallapureddy holds Connecticut license 042339.

Dr. Tallapureddy's primary practice is Mouli Associates, at 200 Hemlock Ave, South Windsor, CT 06074 in Capitol County. The practice phone is (860) 471-8030.

Dr. Tallapureddy's primary practice is Mouli Associates in South Windsor, Connecticut. Dr. Tallapureddy is also affiliated with Hartford Hospital. The medical group on file is Zenicure Medical. Dmand AI also links Dr. Tallapureddy to 3 more hospitals, 5 hospices, 4 home health agencies, 2 skilled nursing facilities and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tallapureddy practices, 16 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Tallapureddy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Tallapureddy is licensed in Connecticut.

CMS data shows 1,063 Medicare services from Dr. Tallapureddy across 14 procedure codes in 2024, for 324 Medicare patients. Medicare paid $88,667 for them.

CMS counts 324 Medicare patients who saw Dr. Tallapureddy in 2024. The largest group is 85 and over, with 110 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tallapureddy's median patient age at 52, with 66% women.

In 2024, Dr. Tallapureddy wrote 32,700 Medicare Part D claims for 709 patients. 87% of them were for generic drugs. CMS names the drug for 31,817 of them, across 256 drugs with 11 or more claims each, at $1,963,325 in total drug cost. In 2023, CMS named 21,915 claims across 227 drugs.

Dr. Tallapureddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tallapureddy as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 839 general payments to Dr. Tallapureddy from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,407.